BWX Technologies, Inc.

(New York Stock Exchange)
Slightly Bullish +25

BWX Technologies, Inc. $BWXT Shares Sold by Arrowstreet Capital Limited ...

πŸ“‰ Arrowstreet Capital Limited Partnership trimmed its BWXT holdings by 13.5% in Q1, reducing its stake from 667,783 shares to 491,360 shares.

πŸ“ˆ Mirae Asset Global Investments acquired a new position worth approximately $9.75 million in the fourth quarter.

πŸ“ˆ Massachusetts Financial Services Co. MA increased its stake by 18.7% to own 1,375,740 shares valued at $237.8 million.

πŸ“ˆ MGO One Seven LLC significantly raised its position by 354.7% in the fourth quarter.

πŸ“ˆ Intech Investment Management LLC and Oak Thistle LLC also increased their holdings by 22.7% and 266.3% respectively.

🏦 Deutsche Bank upgraded BWXT from 'hold' to 'buy' with a price target increase to $255.00.

πŸ“‰ Wells Fargo initiated coverage on the stock with an 'underweight' rating and a $200.00 price target.

πŸ’° The company recently paid a quarterly dividend of $0.27 per share, resulting in a 0.6% annualized yield.

πŸ‘” CFO Michael Thomas Fitzgerald sold 2,417 shares for approximately $505,757 under an SEC filing.

πŸ‘” CEO Rex D. Geveden sold 10,000 shares for approximately $2.05 million via a Rule 10b5-1 trading plan.

🏭 BWXT serves as a primary supplier of nuclear propulsion systems for the U.S. Navy and develops small modular reactors (SMRs).

πŸ’Š The company is also a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.

πŸ“Š The stock currently trades with a market cap of $15.98 billion and a P/E ratio of 46.65.

πŸ“‰ Institutional ownership stands at 94.39% across hedge funds and other institutional investors.

πŸ“ˆ The consensus analyst price target is set at $228.00 with an average rating of 'Moderate Buy'.

Bullish Signals
  • Deutsche Bank upgraded BWXT from a 'hold' to a 'buy' rating and raised its price target from $205.00 to $255.00.
  • Seaport Research Partners upgraded the stock from 'neutral' to 'buy' with a $245.00 price objective.
  • Wall Street Zen upgraded BWXT from 'hold' to 'buy' in a recent report.
  • Multiple institutional investors, including Mirae Asset and Massachusetts Financial Services, increased their stakes significantly in the fourth quarter.
  • The company maintains a strong balance sheet with a current ratio of 2.40 and a quick ratio of 2.33.
  • BWX Technologies holds a dominant position as a specialized supplier for U.S. Navy nuclear propulsion systems.
Risk Factors
  • Wells Fargo initiated coverage on the stock with an 'underweight' rating and a $200.00 price target.
  • CEO Rex D. Geveden sold 10,000 shares representing a 4.71% decrease in his direct ownership position.
  • CFO Michael Thomas Fitzgerald sold 2,417 shares representing a 25.99% decrease in his personal stock ownership.
  • Arrowstreet Capital Limited Partnership reduced its holdings by 13.5% during the first quarter.
Full Analysis
Arrowstreet Capital Limited Partnership reduced its stake in BWX Technologies, Inc. (NYSE:BWXT) by 13.5% during the first quarter, selling 76,423 shares to hold a remaining position of 491,360 shares valued at approximately $100.5 million. While Arrowstreet trimmed its holdings, several other institutional investors increased their positions in the fourth quarter, including Mirae Asset Global Investments which established a new stake worth roughly $9.8 million, and Massachusetts Financial Services Co. MA which grew its ownership by 18.7% to hold over 1.37 million shares. Analyst sentiment regarding BWXT remains mixed but generally positive, with Deutsche Bank upgrading the stock from a 'hold' to a 'buy' and raising its price target to $255.00, while Wells Fargo initiated coverage with an 'underweight' rating and a $200.00 target. The consensus average rating is currently a 'Moderate Buy' with a collective price target of $228.00. Recent insider activity includes CFO Michael Thomas Fitzgerald selling 2,417 shares and CEO Rex D. Geveden selling 10,000 shares under pre-arranged trading plans. BWX Technologies operates as a specialized supplier of nuclear components and services, primarily supporting the U.S. Navy's naval nuclear reactors while also developing small modular reactors (SMRs) and medical radioisotopes for commercial markets. Financially, the company trades with a market capitalization of $15.98 billion and a P/E ratio of 46.65, having recently paid a quarterly dividend of $0.27 per share to stockholders of record on May 19th.